PCR 분자진단 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global PCR Molecular Diagnostics Market size was valued at USD 8.67 Billion in 2024 and is poised to grow from USD 9.16 Billion in 2025 to USD 14.28 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global PCR molecular diagnostics market is experiencing significant growth fueled by the demand for precise and timely diagnostic testing across various health conditions. This innovative technology enables the amplification and detection of specific DNA or RNA sequences, enhancing the ability to diagnose infectious diseases and genetic disorders effectively. Despite facing challenges such as high costs, complexity, and specialized training requirements, the market continues to expand due to the rising prevalence of diseases and the increasing emphasis on personalized medicine. Emerging technological advancements, including portable devices and integration with next-gen sequencing and digital health platforms, create opportunities for broader adoption and multiplex testing. The focus on targeted therapies and precision medicine indicates a strong future for PCR molecular diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global PCR Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global PCR Molecular Diagnostics Market Segments Analysis

Global PCR Molecular Diagnostics Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Instrument, Reagents and Consumables and Software. Based on Application, the market is segmented into Infectious Disease Testing, Oncology Testing and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global PCR Molecular Diagnostics Market

The global PCR molecular diagnostics market is significantly influenced by the rise of precision medicine, which emphasizes customized medical treatments tailored to an individual's genetic profile. PCR molecular diagnostics are essential for detecting genetic variations and biomarkers linked to various diseases, facilitating the development of personalized treatment plans. As healthcare systems increasingly integrate precision medicine strategies to improve patient outcomes, the demand for PCR molecular diagnostics is projected to grow substantially. This method ensures that treatments are more effective and targeted, reinforcing the importance of accurate diagnostic tools in modern medical practices.

Restraints in the Global PCR Molecular Diagnostics Market

The high costs associated with PCR molecular diagnostics often serve as a significant barrier, particularly in resource-constrained environments and areas with limited healthcare funding. Expenses related to specialized equipment, essential reagents, and the need for trained personnel can restrict accessibility and hinder the adoption of these technologies, especially in developing nations. These financial limitations create challenges to the widespread integration and effective utilization of PCR molecular diagnostics in healthcare systems. Addressing these cost barriers is essential for improving accessibility and facilitating the broader implementation of PCR testing across various regions, ultimately enhancing diagnostic capabilities and health outcomes.

Market Trends of the Global PCR Molecular Diagnostics Market

The Global PCR Molecular Diagnostics market is witnessing a significant trend toward the integration of PCR technology with digital health platforms and telehealth solutions. This convergence enhances the accessibility and efficiency of PCR testing by facilitating remote test ordering, result reporting, and comprehensive data management. Healthcare providers can leverage this integration to monitor patients from a distance, efficiently track disease outbreaks, and streamline diagnostic processes, ultimately improving patient outcomes. The growing demand for rapid and accurate diagnostics in a digitally-driven healthcare environment underscores the importance of this trend, positioning it as a pivotal development in the evolution of molecular diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global PCR Molecular Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instrument
  • Standard PCR Systems
  • Digital PCR Systems
  • Real-time PCR Systems
• Reagents and Consumables
• Software

Global PCR Molecular Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Other Applications

Global PCR Molecular Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Others

Global PCR Molecular Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN Manchester Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations